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Objective: Develop a non-terminal animal model of acute joint injury that demonstrates clinical and
morphological evidence of early post-traumatic osteoarthritis (PTOA).
Methods: An osteochondral (OC) fragment was created arthroscopically in one metacarpophalangeal
(MCP) joint of 11 horses and the contralateral joint was sham operated. Eleven additional horses served
as unoperated controls. Every 2 weeks, force plate analysis, ﬂexion response, joint circumference, and
synovial effusion scores were recorded. At weeks 0 and 16, radiographs (all horses) and arthroscopic
videos (OC injured and sham joints) were graded. At week 16, synovium and cartilage biopsies were
taken arthroscopically from OC injured and sham joints for histologic evaluation and the OC fragment
was removed.
Results: OC fragments were successfully created and horses were free of clinical lameness after fragment
removal. Forelimb gait asymmetry was observed at week 2 (P ¼ 0.0012), while joint circumference
(P < 0.0001) and effusion scores (P < 0.0001) were increased in injured limbs compared to baseline from
weeks 2 to 16. Positive ﬂexion response of injured limbs was noted at multiple time points. Capsular
enthesophytes were seen radiographically in injured limbs. Articular cartilage damage was demonstrated
arthroscopically as mild wear-lines and histologically as superﬁcial zone chondrocyte death accompanied
by mild proliferation. Synovial hyperemia and ﬁbrosis were present at the site of OC injury.
Conclusion: Acute OC injury to the MCP joint resulted in clinical, imaging, and histologic changes in
cartilage and synovium characteristic of early PTOA. This model will be useful for deﬁning biomarkers of
early osteoarthritis and for monitoring response to therapy and surgery.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Joint trauma related to sports or other types of injury can cause
acute inﬂammation, cartilage damage, and a signiﬁcant increase in
the long-term risk for the development of osteoarthritis (OA). In the
United States, approximately 12% of the overall prevalence of
symptomatic OA in humans is attributable to post-traumatic OA
(PTOA), which corresponds to approximately 5.6 million adults1.
Traumatic joint injury often occurs in younger adults, predisposing
them to pain and disability from PTOA by middle-age2.
Early therapeutic intervention would ideally slow or halt the
progression of OA. However, the etiopathogenesis of PTOA is not
well understood and the relationship between the severity ofT.N. Trumble, College of Vet-
ty of Minnesota, 1365 Gortner
2-624-2676; Fax: 1-612-625-
).
s Research Society International. Pcartilage injury and risk of joint degeneration has not been
deﬁned3e5. Because the time between injury and onset of PTOA is
often lengthy and tissue samples are difﬁcult to acquire, the path-
ological characteristics of disease progression are difﬁcult to study
in humans. A variety of animal models have been developed to
study different types of acute joint injury6e11. All currently available
models are terminal studies with highly variable translational
beneﬁt for clinical and morphological understanding of the onset
and progression of OA12.
Osteochondral (OC) fragmentation of the proximal phalanx in
the metacarpophalangeal (MCP) joint is a common injury in race-
horses that arises from hyperextension of the MCP joint. The initial
clinical symptoms include several days of lameness (pain) associ-
ated with synovial effusion. If untreated, OA will often develop in
these animals because the OC fragment creates partial to full-
thickness cartilage erosion on the opposing cartilage surface of
the third metacarpal bone13,14. As such, creation of an OC fragment
in the MCP joint may serve as a useful model in the study of PTOA.
Furthermore, because removal of OC fragments in clinical cases willublished by Elsevier Ltd. All rights reserved.
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conceivable that the model can be non-terminal by removing the
OC fragment at the end of the study period. Creation of an OC injury
in the equine carpal joint has been used as an OA model to test
various therapeutics16,17, showing translational beneﬁt to
humans18. However, like other OAmodels, horses are euthanized at
the end of the study due to severity of injury. Compared to other
animals, horses are ideal for translational human OA studies
because of their athleticism, ability to carefully control exercise,
and the size of equine MCP joints facilitates arthroscopic evalua-
tion, serial arthrocentesis, and adequate arthroscopic tissue sam-
pling. Thus, the equine MCP joint is amenable to creation of a
traumatic injury model of OA that allows for ample data collection,
while not requiring euthanasia of the animal at the end of the study.
The purpose of this study was to develop a non-terminal animal
model of acute joint injury that demonstrated clinical and
morphological evidence of the onset and progression of PTOA. We
hypothesized that creation of an OC injury in the MCP joint of
horses would result in clinical, radiographic, arthroscopic, and
histologic changes characteristic of early PTOA. This non-terminal
injury model would be useful for deﬁning biomarker changes of
early OA and for monitoring responses to therapy and surgery.
Methods
Animals
Twenty-two clinically normal Quarter Horses that were free of
lameness and had radiographically normal MCP joints were used.
Horses were divided into two groups: (1) horses that had an OC
fragment created arthroscopically on the proximal dorsomedial
aspect of the ﬁrst phalanx in one randomly chosen MCP joint and a
sham arthroscopic operation in the contralateral joint (n ¼ 11) at
week 0 (baseline); and (2) unoperated control horses (n ¼ 11). In
the injured group, an incongruent surface was created by the OC
fragment that subsequently caused a chondral lesion on the
opposing third metacarpal medial condyle (lesion of interest). In a
pilot study of this model by some of the authors (TNT, MPB, KAM),
arthroscopic evaluation showed that chondral lesions were mini-
mal or absent at 8 weeks, but were well established by 24 weeks
(details in Supplementary materials; S-Fig. 1). Based on this pilot
data, week 16was chosen as the end-point of the current study. The
OC fragment was therefore removed at week 16 to prevent further
chondral damage. For assessment of parameters, the OC injured
and shamMCP joints were assessed separately in each horse, when
applicable, and both MCP joints were combined for the control
group. Therefore, the OC injured, sham, and control joints were
analyzed as three separate groups. Longitudinal changes within
each group over time were compared to week 0, and all three
groups were compared to each other over time.
The OC injured group included six females and ﬁve castrated
males, with amean standard deviation (SD) age of 5.61.6 years;
control horses included ﬁve females and six castrated males, with a
mean age of 6.4  2.1 years. All horses were exercise restricted in
stalls (4 m  4 m) for 2 weeks, beginning at week 0, and were then
turned out in small paddocks (60 m  40 m) for the duration of the
16 week study. All horses were exercised on a high-speed treadmill
5 days/week from week 2 to week 16 (details in Supplementary
materials). All procedures were approved by the University of
Minnesota Institutional Animal Care and Use Committee.
Surgical procedures
At week 0, an OC fragment was created arthroscopically on the
axial aspect of the proximal dorsomedial eminence of the ﬁrstphalanx in one randomly chosen MCP joint of the 11 OC injured
horses [Fig. 1(A and B)]. Using a 6 mm bone gouge, three cuts,
approximately 3e4 mm deep, were made through cartilage and
subchondral bone [Fig. 1(C)]. This formed approximately 3/4 of the
circumference of a circle, leaving the joint capsular attachment on
the dorsal aspect intact. A 4 mm osteotome was placed under the
medial cut and tapped with a mallet (medial to lateral, angled
about 30 down from the joint surface to a depth of 3e4 mm) to
dislodge the fragment from the underlying subchondral bone
[Fig. 1(D)]. The resulting fragment was repositioned back into the
fracture bed before closure of the joint so that the subchondral
fracture bed was not directly exposed to the opposing chondral
surface, thus resembling a naturally occurring OC fragment
[Fig. 1(E)]. The entire dorsal pouch of the OC injured joint (prior to
and after creation of the fragment) and contralateral (sham) joint
was explored and the condition of the articular cartilage and sy-
novial membrane digitally documented (Smith & Nephew, And-
over, MA). Samples (2e5mm in length) of synovial membranewere
collected arthroscopically from the medial and lateral dorsal joint
capsule of all OC injured joints and from only themedial side in ﬁve
of 11 sham operated joints. All operated joints were lavaged to
remove debris and were routinely closed. Morphine (45 mg) was
injected into OC injured joints. Horses were stall-rested until suture
removal at 14 days (post-operative care detailed in Supplementary
materials). Control horses were stall-rested for 14 days tomimic the
OC injured horse protocol.
At week 16, OC injured horses underwent a second arthroscopy
to remove the OC fragment. Both OC injured and sham joints were
explored and digitally documented [Fig. 2(A)]. Full-thickness
articular cartilage samples from OC injured joints (n ¼ 11) were
obtained from the cartilage surface of the dorsal distal third
metacarpal medial condyle that opposed the OC fragment (kissing
lesion wear-line). A 2 mm osteotome was used to make two linear,
full-thickness cuts parallel to the kissing lesion (2 mm apart). The
osteotome was then advanced in a parallel fashion through the
articular cartilage into subchondral bone in a proximal to distal
direction and an approximately 5e6 mm long section of cartilage
and bone was elevated [Fig. 2(B)]. The sample was carefully
removed to avoid crush injury. For comparison, cartilage samples
were also obtained from the same location in the contralateral
sham joints of six randomly selected horses. Synovial membrane
samples were collected from the medial and lateral dorsal joint
capsule of all OC injured joints and from the medial side of all sham
joints. After sample collection, the OC fragment was removed
arthroscopically. Joints were lavaged and routinely closed.
Morphine (45 mg) was injected into OC injured joints and the six
sham joints from which cartilage samples were taken. Post-
operative care was conducted as described for the ﬁrst surgery.
All horses were evaluated for lameness 3e4weeks post-operatively
and subsequently adopted out according to University protocol.
Clinical assessment of the joint
MCP joint circumference measurements (details in
Supplementary materials), synovial ﬂuid viscosity scores, and joint
effusion scores were evaluated in both forelimbs in all horses at
weeks 0, 1, 2, then every 2 weeks until week 16. Joint effusion was
subjectively graded as follows: 0 ¼ none; 1 ¼ mild; 2 ¼ moderate;
or 3 ¼ severe, based on visual appearance and palpable swelling of
the joint pouches. With the limb in ﬂexion, synovial ﬂuid was ob-
tained at each time point using a 20 g  1.5 in. needle from the
palmar pouch of each MCP joint without lavage (for future
biomarker analysis) and viscosity was measured (details in
Supplementary materials). The presence or absence of hemarth-
rosis at sample collection was noted.
Fig. 2. Arthroscopic images of OC injured joints at week 16 with the third metacarpal bone on top and the ﬁrst phalanx on the bottom (medial is to the left, lateral to the right).
(A) OC fragment on proximal ﬁrst phalanx (outlined by short arrows) and kissing lesion wear-lines in the articular cartilage of distal medial third metacarpal bone (long arrows).
(B) Elevation of full-thickness articular cartilage sample from the third metacarpal bone using a 2 mm osteotome. The sample is centered over the articular cartilage wear-lines.
Fig. 1. Anatomy of the equine MCP joint and the speciﬁc site for creation of OC fragment. (A) Left MCP joint in a live horse, with the third metacarpal bone (top) and ﬁrst phalanx
(bottom) outlined. (B) Cadaver specimen of the MCP joint in the same orientation as (A). The joint has been opened and ﬂexed to show the distal end of the third metacarpal bone
and the proximal end of the ﬁrst phalanx. The site of surgical creation of the OC fragment on the proximodorsal ﬁrst phalanx and site of the chondral lesion that develops secondary
to the OC fragment (and site of histologic biopsy) on the dorsodistal third metacarpal bone are outlined. (CeE) Arthroscopic images of OC fragment creation on the ﬁrst phalanx in
the same orientation as (A) and (B) with the third metacarpal bone visible above the ﬁrst phalanx. (C) Cuts made with a 6 mm bone gouge through articular cartilage and sub-
chondral bone. (D) Elevation of the OC fragment from the subchondral bone bed with 4 mm osteotome. (E) Appearance of the OC fragment at the end of surgery. For all images,
medial is to the left and lateral to the right.
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Kinetic gait analysis has beenused to objectively distinguishpain
(lameness) in horses19. Forelimb symmetry was assessed on all 22
horses using kinetic analysis (Advanced Medical Technology, Inc.,
Watertown, MA) at baseline and every 2 weeks for the study dura-
tion (details in Supplementary materials). In addition, subjective
lameness scores (American Association of Equine Practitioners
(AAEP) grading scheme20) and pain response to ﬂexion of the distal
limbwere analyzed throughout the study, as well as out to 4 weeks
after OC fragment removal (details in Supplementary materials).
Radiography
Bilateral MCP joint radiographs were taken on all 22 horses at
baseline and at week 16 using digital radiography (Sound-Eklin,
Carlsbad, CA). Further details of views obtained are listed in
Supplementary material. Radiographic images of baseline and
week 16 were blinded and evaluated independently by two eval-
uators (TNT, MPB; scores for each joint were averaged) using a
previously reported OC injury scoring system of 0e3021.
Arthroscopy
Arthroscopic exploration videos of OC injured and sham oper-
ated MCP joints were blinded and evaluated independently (TNT,
MPB; scores for each joint were averaged) using a modiﬁed scoring
system for evaluation of articular changes in response to OC
injury21. Brieﬂy, the total arthroscopic score (0e44) encompassed
cartilage changes (0e23), synovial membrane changes (0e15), and
the presence/size of the fragment(s) (0e6) (S-Table 1). Kissing
lesion depth (CDK) was a sub-category of cartilage damage that
assessed the articular cartilage change on the third metacarpal
medial condyle in the region directly opposite the OC fragment
where the cartilage sample was taken for histology (Fig. 2). Control
horses were not subjected to arthroscopic evaluation.
Histology
Cartilage: Immediatelyafter removal fromthe joint atweek16, full-
thickness articular cartilage samples of the third metacarpal medial
condyle from OC injured joints (11/11) and sham joints (6/11) were
oriented longitudinallyand theproximalendstained lightlywith India
ink to allow proper orientation for embedding (processing details in
Supplementarymaterial). Transverse sections (4 mm)weremadenear
themiddle (fromaproximal todistal orientation) of each sampleusing
a rotary microtome (Leica, Buffalo Grove, IL) and stained with hema-
toxylin and eosin (H&E) or Safranin O/fast green (all stained at the
same time). Slideswereblindedandexamined independentlyvia light
microscopy (CSC,MKB; scoreswere averaged). Cartilage sampleswere
graded for ﬁbrillation/ﬁssuring of the articular surface, chondrocyte
cluster formation, chondrocyte death, and decreased staining for
matrix proteoglycan (PG) using modiﬁcations of the microscopic
grading system for articular cartilage in horses22. Fibrillation/ﬁssuring
was scored 0e4 as previously described22. Cluster (complex chon-
drone) density, where cluster was deﬁned as multiple chondrocytes
sharing pericellular matrix within a chondrone23, was determined by
counting the number of clusters in each sample and dividing by the
total cartilage area. The total cartilage area was deﬁned as the area
between the superﬁcial surface of articular cartilage and the most
superﬁcial tide mark. Percentage of the cartilage occupied by dead
chondrocytes was quantitatively evaluated using histomorphometry,
bymeasuring the area occupied by dead chondrocytes divided by the
total cartilage area and multiplying that value times 100 (details in
Supplementarymaterials; S-Fig. 3). To assess the loss ofmatrix PG, thepercentage of the articular cartilage area thatwas composed ofmatrix
exhibiting complete loss of Safranin O staining was determined by
dividing the area of stain loss by the total cartilage area.
Synovial membrane: Week 0 and week 16 synovial membrane
samples were placed in 10% neutral-buffered formalin immediately
after collection and were processed routinely. Sections (4 mm) were
prepared and stained with H&E. Slides were blinded and subjec-
tively graded independently (CSC, MKB; scores were averaged) to
evaluate cellular inﬁltrate (0e4), vascularity (0e4), intimal hyper-
plasia (0e4), subintimal edema (0e4), and subintimal ﬁbrosis (0e
4) as previously described22.
OC fragment: Details in Supplementary materials; S-Fig. 4.
Statistical analysis
Datawas assessed for normality using the ShapiroeWilk test for
normality and outliers were identiﬁed in the gait analysis data
using extreme studentized deviate tests and removed from further
analyses (details in Gait Analysis section of Supplementary
material). For MCP joint assessment data and forelimb symmetry,
a repeated measure analysis of variance (ANOVA) with Tukey’s for
multiple comparison was used for analysis. To verify that as-
sumptions were fulﬁlled for the repeated measures ANOVA,
normality was examined graphically for skewness or kurtosis as
well as with the ShapiroeWilk test, within group variances were
examined to look at the homogeneity of variance, and sphericity
was examined using a Mauchly’s test and adjusted for using the
GreenhouseeGeisser adjustment. Radiographic, arthroscopic, and
synovial membrane histological scores were analyzed using a
KruskaleWallis test with a Dunn’s Multiple Comparison Test. A
ManneWhitney U test was performed on histologic cartilage
scores. Correlations were assessed using the Spearman rank
correlation. P < 0.05 was considered signiﬁcant.
Results
OC fragments were successfully created with minimal to no
collateral iatrogenic damage in six right and ﬁve left MCP joints. At
week 16, all OC fragments were in place at arthroscopic evaluation,
with histologic evidenceofﬁbrocartilaginous healing to bone in 10 of
11 fragments (S-Fig. 4). Removal of OC fragments atweek 16 resulted
in minimal subjective clinical signs of lameness by 1 month after
surgery (mean, 95% Conﬁdence Interval (CI); 0.3 out ofﬁve American
Association of Equine Practitioners (AAEP) grading system20, 0.16,
0.71). There were no complications related to the OC fragment.
Clinical assessment of the joint
OC injured joints had higher effusion scores compared to
baseline, sham, and control joints, whereas sham and control joints
were not different from baseline or each other (Fig. 3). OC injured
joints also had greater joint circumference changes from baseline at
all time points except week 1 and this change was greater than
sham and control joints at multiple time points (S-Fig. 5). Control
and sham joints also demonstrated joint circumference changes
from baseline, but there were no differences between sham and
control joints. Synovial ﬂuid viscosity decreased in OC injured
(weeks 1 and 2) and sham joints (week 1) compared to baseline and
controls (S-Fig. 6). Hemarthrosis was only present in one of 440
MCP synovial ﬂuid collections.
Gait analysis
The percent symmetry of peak vertical force decreased at week
2 compared to baseline in OC injured horses, but there were no
Fig. 3. Clinical assessment of MCP joint effusion and kinetic gait analysis. (A) Mean
(95% CIs) effusion scores (0e3) over a 16 week period for each MCP joint group (OC
injured, sham, control), and differences between each group at each time point
(Tukey’s post hoc). (B) Mean (95% CIs) forelimb percent symmetry scores of peak
vertical force in OC injured and control horses over a 16 week period compared to
baseline and compared to each other. A decrease in symmetry indicates pain (lame-
ness). Repeated measures P-values are listed. (A) Differences from baseline are rep-
resented as: OC injured MCP joints to baseline: þþþP < 0.001. Differences between
groups are represented as: OC injured MCP joint to sham MCP joint: ***P < 0.001,
*P < 0.05; OC injured MCP joint to control MCP joint: ^^^P < 0.001, ^^P < 0.01,
^P < 0.05. (B) Differences from baseline are represented as: OC injured horses to
baseline: þþP ¼ 0.0012.
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point (Fig. 3). Distal limb ﬂexion resulted in an increased pain
response in OC injured limbs at weeks 2, 6, 10, and 12 compared to
baseline or sham joints, and at weeks 2 and 10 compared to control
joints (S-Fig. 7).
Radiography
Mean total radiographic and enthesophyte scores demonstrated
more change in OC injured joints (S-Fig. 8) vs baseline, sham, and
control joints (Table I). There were no differences for subchondral
bone sclerosis/lucency or joint space narrowing. Joint effusion at
week 16 correlated with the enthesophyte score (R ¼ 0.580;
P ¼ 0.005) and total radiographic score (R ¼ 0.814; P < 0.0001) in
OC injured limbs at week 16.Table I
Mean radiographic scores (95% CIs) from OC injured, sham, and control MCP joints at w
Radiographic scores Week 0
OC injured (n ¼ 11) Sham (n ¼ 11) Cont
Osteophyte (0e6) 0.18 (0.09, 0.45) 0.18 (0.22, 0.59) 0.39
Enthesophyte (0e6) 0.18 (0.09, 0.45) 0.09 (0.11, 0.29) 0.50
Total radiographic score (0e30) 0.50 (0.08, 0.92) 0.45 (0.03, 0.94) 1.09
Bolded values represent a signiﬁcant increase in OC injured joints at week 16 compared
injured to sham: ***P < 0.001; OC injured to control: ^^^P < 0.001, ^^P < 0.01. n ¼ N
parenthetically next to each radiographic category in the ﬁrst column.Arthroscopy
Cartilage and total arthroscopy scores were higher at week 16
than baseline for the OC injured joints (Table II). Synovial mem-
brane, cartilage and total arthroscopy scores were higher in OC
injured joints compared to sham joints at week 16 (Table II).
Arthroscopic scores correlated with multiple clinical and radio-
graphic scores (Table III).
Histology
Cartilage: Fibrillation/ﬁssuring, chondrocyte cluster formation,
and chondrocyte death scores on the third metacarpal medial
condyle were higher in OC injured vs sham joints at week 16
[Table II; Fig. 4(A and B)]. Loss of matrix PG staining [Fig. 4(C and D)]
was not different between injured and sham cartilage (P ¼ 0.760).
Chondrocyte death and cluster formation correlated with multiple
clinical, radiographic and arthroscopic scores (Table IV). In addition,
chondrocyte clusters correlatedwith chondrocyte death (R¼ 0.776,
P < 0.0001), while there was no correlation between ﬁbrillation/
ﬁssuring and chondrocyte death (R ¼ 0.352, P ¼ 0.165).
Synovial membrane: Synovial vascularity and subintimal ﬁbrosis
scores were higher in the medial synovial membrane from OC
injured joints at week 16 compared to baseline [Fig. 4(E and F)];
however, there were no differences in synovial scores between OC
injured and sham joints (Table II). Medial and lateral synovial scores
for OC injured joints were not different from each other at baseline
or week 16. The subintimal ﬁbrosis score correlated with clinical,
radiographic and arthroscopic scores, and vascularity correlated
with arthroscopy scores (Table IV). In addition, synovial vascularity
correlated with subintimal ﬁbrosis (R ¼ 0.764, P < 0.0001), and
subintimal ﬁbrosis correlated with chondrocyte death (R ¼ 0.770,
P < 0.0001).
OC fragment: OC fragments were composed primarily of an
admixture of woven and lamellar bone (some areas of which were
necrotic), ﬁbrocartilage, and degenerate hyaline cartilage, and were
accompanied by reactive/ﬁbrotic synovium (S-Fig. 4).
Discussion
OC fragments were created arthroscopically in all MCP joints
with minimal iatrogenic collateral damage. Use of a bone gouge
facilitated creation of semi-circular fragments of equal size in the
same location of each horse that resulted in an incongruent artic-
ular surface. This incongruence was maintained throughout the
study even though most fragments (10/11) had histologic evidence
of ﬁbrocartilaginous healing to the subchondral bone, similar to a
previous OC injury model in the horse where nine of 12 fragments
healed back to underlying bone24. The articular incongruity caused
cumulative increased contact stress at a focal site opposite the
fragment (kissing lesion) that led to cartilage degeneration over
time (wear-lines). Therefore, our model created a focal superﬁcial
cartilage lesion with minimal variability, which may be moreeeks 0 and 16
Week 16
rol (n ¼ 22) OC injured (n ¼ 11) Sham (n ¼ 11) Control (n ¼ 22)
(0.04, 0.73) 0.77 (0.18, 1.36) 0.27 (0.04, 0.59) 0.70 (0.27, 1.14)
(0.14, 0.86) 1.82 (0.83, 2.81)***^^ 0.18 (0.09, 0.45) 0.73 (0.36, 1.09)
(0.47, 1.72) 7.59 (5.77, 9.42)***^^^ 0.82 (0.31, 1.32) 1.71 (0.93, 2.48)
to week 0 (P < 0.05). Week 16 differences between groups are represented by: OC
umber of MCP joints evaluated in each group. The potential score range is listed
Table II
Summary of mean arthroscopic and histologic data (95% CIs) obtained from OC injured and sham MCP joints at weeks 0 and 16
Week 0 Week 16
Arthroscopic scores OC injured (n ¼ 11) Sham (n ¼ 11) OC injured (n ¼ 11) Sham (n ¼ 11)
Synovial membrane (0e15) 1.36 (0.84, 1.89) 0.95 (0.28, 1.63) 3.73 (2.16, 5.29)* 1.27 (0.59, 1.95)
Cartilage score (0e23) 1.68 (0.67, 2.69) 1.64 (0.36, 2.91) 10.23 (8.78, 11.67)*** 1.77 (0.49, 3.05)
Total arthroscopy score (0e44) 3.05 (1.91, 4.18) 2.68 (1.15, 4.22) 18.14 (15.38, 20.89)*** 3.14 (1.74, 4.53)
Histologic scores OC injured Sham OC injured Sham
Cartilage (n ¼ 11) (n ¼ 6)
Fibrillation/ﬁssuring (0e4) 1.27 (0.96, 1.59)* 0.66 (0.12, 1.21)
Cluster formation (number/area) 8.14 (4.07, 12.21)** 1.33 (0.89, 3.54)
Chondrocyte death (% area) 6.0 (4.1, 7.3)** 2.0 (0.8, 3.0)
Decreased matrix PG (% area) 15.0 (6.4, 23.0) 14.0 (0.5, 26.0)
Synovium (medial) (n ¼ 11) (n ¼ 5) (n ¼ 11) (n ¼ 5)
Cellular inﬁltrate (0e4) 0.95 (0.72, 1.19) 1.20 (0.64, 1.76) 0.95 (0.64, 1.27) 1.14 (0.98, 1.29)
Vascularity (0e4) 0.68 (0.41, 0.95) 0.50 (0.06, 0.94) 1.86 (1.28, 2.45) 1.00 (0.46, 1.54)
Intimal hyperplasia (0e4) 0.23 (0.09, 0.54) 0.20 (0.14, 0.54) 0.32 (0.15, 0.49) 0.14 (0.08, 0.35)
Subintimal edema (0e4) 0.32 (0.09, 0.54) 0.60 (0.42, 1.62) 0.77 (0.22, 1.32) 0.27 (0.04, 0.59)
Subintimal ﬁbrosis (0e4) 1.09 (0.80, 1.38) 0.80 (0.09, 1.51) 2.41 (1.87, 2.95) 1.36 (0.99, 1.73)
Bolded values represent a signiﬁcant increase in OC injured joints at week 16 compared to week 0 (P < 0.05). Week 16 differences between OC injured and sham groups are
represented by: ***P< 0.001, **P< 0.01, *P< 0.05. n ¼ Number of MCP joints evaluated in each group. The potential score range or description is listed parenthetically next to
each arthroscopic and histologic category in the ﬁrst column.
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anterior cruciate ligament (ACL) rupture) where articular surface
contact stress increases at variable sites creating variability in
lesion morphology10. Arthroscopic surgery at week 16 allowed
collection of small, but adequate cartilage and synovial biopsies as
well as removal of the OC fragment to provide relief from the in-
congruity. Collection of clinical and histologic data and removal of
the inciting cause of injury through minimally invasive techniques
allowed the horses to be free of clinical signs of lameness (0.3 out of
ﬁve subjective lameness grade) by 1 month after OC fragment
removal. To our knowledge, this is the ﬁrst non-terminal joint
injury model that provides the possibility for evaluating the joint
environment immediately after injury as well as after surgical
removal of the inciting cause.
Arthroscopically, wear-lines on cartilage were identiﬁed on the
articular surface of the third metacarpal bone opposing the OC
fragment and were positively correlated with chondrocyte death
and cluster formation. These superﬁcial articular cartilage lesions
appeared to be similar to those occurring in the human patella25, in
which wear-lines may represent structural failure of the cartilage
surface. This affects the biomechanical properties of cartilage and
may represent an early stage of degeneration25. In our pilot study
(S-Fig. 1), minimal to no wear-lines could be identiﬁed arthro-
scopically in the three horses examined at 8 weeks, whereas mul-
tiple wear-lines were present in all horses by 24 weeks. In the
current study, the wear-lines identiﬁed arthroscopicallyTable III
Correlations [r e rho values (P-values)] between arthroscopic scores and joint
effusion, joint circumference percent change and radiographic scores in OC injured
MCP joints at week 16
Arthroscopy
Synovium Cartilage CDK Total
Effusion 0.566 (0.006) 0.837 (<0.001) 0.750 (<0.001) 0.802 (<0.001)
JC % change 0.529 (0.011) 0.503 (0.017) 0.467 (0.028) 0.551 (0.008)
R-Enthes 0.297 (0.180) 0.563 (0.006) 0.621 (0.002) 0.459 (0.032)
R-total 0.665 (0.001) 0.850 (<0.001) 0.815 (<0.001) 0.848 (<0.001)
Bolded r values represent statistically signiﬁcant correlations. JC % ¼ joint circum-
ference percent change from baseline, R ¼ radiograph, Enthes ¼ enthesophyte,
CDK ¼ kissing lesion depth (region from which cartilage sample taken).demonstrated multiple histologic changes, including mild ﬁbrilla-
tion, chondrocyte death and the presence of chondrocyte clusters
in the superﬁcial zone. When combining the arthroscopic ﬁndings
of our pilot study with the arthroscopic and histologic ﬁndings of
our larger current study, it is suggestive that the cartilage lesions
identiﬁed at week 16 in our model represent an early stage of PTOA
since there is progressive change in the development of the wear-
lines over time. This is further supported by the presence of
chondrocyte death and cluster formation around the wear-lines at
week 16, which represent some of the earliest signs of cartilage
damage. A study of mechanical trauma on cartilage showed that
chondrocyte apoptosis increased with increasing load7, while
another study suggested that chondrocyte cluster formation may
represent early cartilage repair since the number of proliferating
chondrocytes increased with progression of OA26. In addition, in
other models of OA10,27,28, chondrocyte clusters tend to localize
around areas in which cell death is most pronounced. Our histo-
logical evaluation supported this ﬁnding (Fig. 4) and showed a
positive correlation between cell death and the presence of chon-
drocyte clusters in OC injured cartilage. In most OA studies,
glycosaminoglycan (GAG) release increases from the superﬁcial
zone in response to mechanical trauma7. However, we did not see
any difference in Safranin O staining between the OC injured and
sham cartilage sections at week 16. Our ﬁndings are similar to the
canine groove model, another OA model of subtle chondral injury,
where there was no difference in Safranin O staining even though
there was histologic evidence of structural and cellular differ-
ences29. They demonstrated that subtle changes in PG content
could not be detected by histochemistry even though there was
biochemical evidence of PG release. In general, it appears that
evaluating PG loss using Safranin O/fast green uptake is subjective
and unreliable unless there is complete PG loss, suggesting that this
stain may not be optimal for assessing PG loss with superﬁcial
cartilage lesions22. Safranin O staining may be best when there are
substantial abnormal mechanical forces generated by the injury
where chondrocyte death/proliferation reaches the middle to
deeper cartilage zones resulting in greater PG loss than was iden-
tiﬁed in our model.
Unlike dogs and smaller animals that may ambulate on three
limbs after injury, horses inherently bear weight on all four limbs
unless the pain is severe. This makes the horse useful for objective
Fig. 4. Histologic sections of articular cartilage and synovial membrane samples from sham and OC injured MCP joints. H&E staining of cartilage from a sham joint (A) and an OC
injured joint (B) at week 16. Sham MCP joint cartilage (A) demonstrates a smooth articular surface and nuclear staining of chondrocytes throughout the section. The OC injured MCP
joint cartilage (B) demonstrates superﬁcial ﬁbrillation (black arrows), chondrocyte clusters (red arrow), and areas of loss of nuclear staining (cell death; arrow heads) in the su-
perﬁcial zone of the injured joint cartilage. Safranin O stained sections of articular cartilage from a sham joint (C) and an OC injured joint (D) at week 16 demonstrate superﬁcial loss
of Safranin O staining in the sham joint (C) and a slightly more extensive loss of staining (not statistically signiﬁcant), accompanied by superﬁcial ﬁbrillation, in the injured joint (D).
H&E-stained sections of synovial membrane from an MCP joint prior to creation of the OC fragment at week 0 (E) and from an OC injured joint at week 16 (F), demonstrating the
presence of subintimal ﬁbrosis (black arrows) in the synovium of the injured joint. (AeF) Bar ¼ 100 mm.
Table IV
Correlations [r e rho values (P-values)] of histologic scores with joint effusion, radiographic, and arthroscopic scores in OC injured MCP joints at week 16
Histology cartilage Histology synovium
Fib/ﬁs Clusters Chond. death PG loss Cell inﬁltrate Vascularity Hyperplasia Edema Fibrosis
Effusion 0.167 (0.522) 0.747 (0.001) 0.707 (0.001) 0.240 (0.353) 0.342 (0.119) 0.417 (0.054) 0.152 (0.499) 0.206 (0.359) 0.689 (<0.001)
R-Enthes 0.084 (0.750) 0.428 (0.087) 0.489 (0.046) 0.064 (0.807) 0.224 (0.316) 0.125 (0.581) 0.073 (0.747) 0.146 (0.517) 0.409 (0.059)
R-total 0.363 (0.152) 0.495 (0.043) 0.669 (0.003) 0.027 (0.920) 0.306 (0.167) 0.332 (0.131) 0.431 (0.045) 0.147 (0.514) 0.641 (0.001)
A-synovium 0.348 (0.171) 0.357 (0.160) 0.621 (0.008) 0.047 (0.859) 0.207 (0.354) 0.658 (0.001) 0.306 (0.166) 0.336 (0.126) 0.568 (0.006)
A-CDK 0.420 (0.093) 0.717 (0.001) 0.942 (<0.001) 0.118 (0.652) 0.202 (0.367) 0.516 (0.014) 0.216 (0.335) 0.290 (0.190) 0.754 (<0.001)
A-cartilage 0.351 (0.167) 0.828 (<0.001) 0.897 (<0.001) 0.190 (0.465) 0.222 (0.320) 0.347 (0.113) 0.265 (0.265) 0.106 (0.638) 0.633 (0.002)
A-total 0.397 (0.115) 0.664 (0.004) 0.825 (<0.001) 0.139 (0.594) 0.240 (0.282) 0.458 (0.032) 0.346 (0.115) 0.160 (0.478) 0.627 (0.002)
Bolded r values represent statistically signiﬁcant correlations. Fib/ﬁs ¼ Fibrillation/ﬁssuring, Chond. ¼ chondrocyte, R ¼ radiograph, Enthes ¼ enthesophyte, A ¼ arthroscopy,
CDK ¼ kissing lesion depth (region from which cartilage sample taken).
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sures that the injured limb will remain in use throughout the
duration of the study. In horses, any decrease in peak vertical force
likely results from increased pain in that limb19. OC injury in our
model caused transient pain that could be identiﬁed using ground
reaction forces and subjective response to joint ﬂexion. These
transient signs of pain are consistent with that often seen after
acute joint trauma in humans30,31, where there is initial pain from
intra-articular hypertension, subchondral bone trauma, or soft
tissue injury that subsequently subsides until PTOA becomes
advanced3. We could not determine the speciﬁc source of transient
joint pain in our horses after OC injury, but possibilities include
synovial/capsular inﬂammation, subchondral bone trauma around
the fragment, and/or joint effusion. There was evidence of both
joint effusion and joint circumference changes in OC injured joints
throughout the study, which may have contributed to transient
increased ﬂexion responses from baseline between weeks 2 and 16
(S-Fig. 7), even though lameness decreased over time (Fig. 3). With
PTOA, enthesophyte formation and capsular ﬁbrosis can be po-
tential sources of pain, especially with forced ﬂexion. These were
both identiﬁed at week 16 in our study, but by the design of the
study, we were unable to identify whether they developed earlier
such that they could explain the pain response to ﬂexion at weeks
6, 10, and 12.
Joint effusion was one of our best clinical correlates to the
presence and severity of disease. The exact cause for the effusion in
our model is unknown, but we know that arthroscopic exploration
itself did not cause effusion because there was no increase in
effusion scores in sham operated joints. In the acute period after
injury, joint effusion may be caused by intra-articular bleeding,
increased synovial ﬂuid production, or inﬂammatory cell inﬁltra-
tion secondary to trauma3,32e34. In our study, hemorrhage was
present at the time of OC fragment creation because we fractured
healthy subchondral bone. However, there was no evidence of
blood within the joint during synovial ﬂuid collections at week 1 in
any horse. In fact, hemarthrosis was noted only once thereafter,
indicating that hemorrhage was not a continued source of joint
effusion or pain.
In humans with knee OA, joint effusion can be a common
ﬁnding evenwith minimal to no clinical signs of inﬂammation35. In
most animal models of OA, or PTOA in humans, inﬂammation and
effusion are often present due tomicroscopic particles (joint debris)
that incite acute synovitis viamacrophagic phagocytosis36,37. In our
study, most debris resulting fromOC fragment creationwas lavaged
from the injured joints at the end of the procedure. However, it is
possible that intermittent signs of effusion and pain may have
corresponded with the release of cartilage debris from the score
lines identiﬁed via arthroscopy and histology at week 16, but we
have no direct evidence to support this possibility since there was
minimal histologic evidence of debris within the synovium at week
16. Increased effusion may have been present due to daily treadmill
exercise after acute injury38, which would suggest that there is at
least transient inﬂammation in the joint that may wax and wane
after injury. Even though our study cannot document histologic
evidence of synovitis at week 16, the clinical signs of effusion and
pain (acute lameness byweek 2 and ﬂexion responses at weeks 2, 6,
10 and 12) supports that inﬂammation may come and go in the
early stages of PTOA. In fact, our arthroscopic examination of horses
in our pilot study (S-Fig. 1) demonstrated that there was slight
hyperemia by 8 weeks after injury that progressed to hypertrophy
and hyperplasia of the synovial membrane by week 24. Ultimately,
analysis of biomarkers of inﬂammation in the synovial ﬂuid is
required to characterize the inﬂammatory process after injury.
Regardless, similar to previous studies39,40, we found strong cor-
relations between effusion and arthroscopic synovium andcartilage scores as well as effusion and histologic cartilage scores at
week 16, suggesting that synoviopathy and cartilage degradation
play a role in excessive ﬂuid production and retention. It is also
possible that intimal cells of ﬁbrotic villi have decreased ability to
ﬁlter synovial ﬂuid, resulting in increased effusion. Our study did
demonstrate a non-inﬂammatory ﬁbrotic reaction in the synovium
that was conﬁned to the area of the OC fragment at week 16 and
was correlated to histologic ﬁndings of increased vascularity and
ﬁbrosis in the injured joints. This non-inﬂammatory synovial
response would be similar to other surgically induced OAmodels as
well as early knee OA in humans, where arthroscopy demonstrates
synovial hypertrophy and hyperemia39e44.
Histological evaluation of cartilage from control joints may have
illustrated further differences from injured joints, beyond those
seen in sham joints, and thus was a limitation of the study. How-
ever, histologic changes in sham joints were minimal and no sig-
niﬁcant differences were seen in clinical or radiographic scores
between sham and control joints, other than viscosity scores at
week 1. Therefore, the sham joint may serve as a control for the OC
injured joint, but further biomarker analysis of the ﬂuid from these
horses will help support or refute this premise. Although minimal
radiographic changes were present, additional advanced imaging
such as Magnetic Resonance Imaging (MRI) may have been useful
to identify additional changes in soft tissues or subchondral bone
not typically seen with radiography45,46. Although MRI was not
used in our study, both standing and recumbent magnets can be
used for longitudinal examination of this region in the horse and
should be considered for future studies. However, we were able to
use arthroscopic imaging which is often used as the gold standard
for identiﬁcation and staging of articular cartilage disease47,48 since
it allows better assessment of the cartilage surface and synovial
membrane than MRI, including characterization of the location and
severity of lesions49,50. The large size of the animals used in this
study was advantageous for arthroscopic and histological data
collection, as well as for synovial ﬂuid collection (average 4.3 mL/
MCP joint/sample). However, appropriate facilities and personnel
to handle horses are required, and the cost, although similar to
canine models, is greater than for laboratory animals. Although we
were not able to follow these horses out to 12e24 months after
fragment removal to determine their long-term health, previous
clinical studies where similar naturally occurring OC fragments
have been removed in equine athletes have shown a high per-
centage of return to use13e15.
The lesions identiﬁed in the current study as well as those
identiﬁed in our pilot study do not ﬁt the historical deﬁnition of
OA51. However, the historical deﬁnition arguably ﬁts the more
advanced disease state where there is substantial structural dam-
age tomultiple tissues leading to persistent pain. Although early OA
is muchmore difﬁcult to identify, it is critical to do so because there
may be potential in the early stages of OA to halt or slow the pro-
gression of the disease52. In a recent study to classify patients with
early OA of the knee53, it was suggested that patients could be
deﬁned as having early OA if they had episodes of pain, minimal to
no radiographic changes (KeL grade 0eII), and had either cartilage
lesions identiﬁed by arthroscopy or cartilage/bone/soft tissue le-
sions identiﬁed onMRI. Based on this description, our horses would
be classiﬁed as having early OA because they demonstrated variable
pain throughout the 16 weeks based on force plate and subjective
ﬂexion responses, had minimal radiographic changes and demon-
strated cartilage lesions arthroscopically. In addition, based on
arthroscopic changes identiﬁed at weeks 8 and 24 in our pilot study
(S-Fig. 1), we have evidence that the synovial and chondral changes
progress over time. It is unlikely that these lesions would be self-
limiting and heal spontaneously in the presence of the OC frag-
ment in the joint. In fact, the progressive changes identiﬁed in the
M.K. Boyce et al. / Osteoarthritis and Cartilage 21 (2013) 746e755754articular cartilage from our pilot study are similar to those
described in other models of OA, such as the canine groove
model29. Therefore, we feel that creation of an OC fragment in the
equine MCP joint consistently resulted in acute traumatic injury
with subsequent development of superﬁcial articular changes that
are representative of early PTOA.
In summary, creation of an OC fragment in the equine MCP joint
resulted in consistent clinical, morphological, and histological fea-
tures of acute traumatic injury with subsequent superﬁcial articular
changes. This model provides a suitable non-terminal model of
PTOA that can be used to evaluate the clinical, morphological, and
biochemical changes associatedwith early PTOA. This model will be
useful for deﬁning biomarkers of early OA and for monitoring
response to therapy and surgery.
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